Local company wins Colombia desalination project

The desalination plant is located in the Meta region of Puerto Gaitan and will produce 500,000 barrels of water per day.

By
March 7, 2013 22:56
1 minute read.
Desalination plant (illustrative)

Desalination Plant 311. (photo credit: Courtesy)

Amiad Water Systems, an Upper Galilee-based international water-filtration firm, this week signed an $8 million agreement to implement its technologies in a Colombian oil field.

The company will be providing filtration systems to the Israeli subsidiary Nirosoft, of Ron Lauder’s RWL Water Group, which won a $100m.

Be the first to know - Join our Facebook page.


contract with the firm Pacific Rubiales to build a desalination plant at a central Colombian oil field in August.

The desalination plant is located in the Meta region of Puerto Gaitan and will produce 500,000 barrels of water per day. Its design and construction, as well as operation for 10 years, is being carried out by Nirosoft. Amiad will provide the water with preliminary filtration during the desalination process, the company said.

Amiad will employ its reverse-osmosis membranes for the filtration and will also oversee the construction and maintenance of the filters.

“We are very pleased to cooperate with Nirosoft,” Amiad CEO Arik Dayan said.

“Filtration solutions for the oil market in general and for the market in South America in particular are very important, and Amiad is proud to continue to sell its solutions in markets all over the world.”

Nirosoft CEO Avi Bonibay expressed satisfaction at being able to cooperate with another Israeli firm in an effort to contribute to the local economy.

“In choosing a supplier we must ensure that systems and equipment meet the strict requirements and international standards and will deliver the desired results,” he said. “From our extensive experience with the company Amiad, we are confident that their filtering systems meet the needs and will provide safe and consistent results throughout the duration of the project.”


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS